Starting treatment with angiotensin converting enzyme inhibitors in heart failure: how, where, and how much?
作者信息
Coats A J
出版信息
Br Heart J. 1993 Apr;69(4):282-3. doi: 10.1136/hrt.69.4.282.
Abstract
摘要
相似文献
1
Starting treatment with angiotensin converting enzyme inhibitors in heart failure: how, where, and how much?心力衰竭患者开始使用血管紧张素转换酶抑制剂治疗：如何用药、在何处用药以及用药剂量是多少？
Br Heart J. 1993 Apr;69(4):282-3. doi: 10.1136/hrt.69.4.282.
2
Angiotensin-converting enzyme inhibitors or beta-blockers in heart failure: does it matter who goes first?
Circulation. 2005 Oct 18;112(16):2380-2. doi: 10.1161/CIRCULATIONAHA.105.586545.
3
ACE inhibitors for heart failure: a question of dose.用于治疗心力衰竭的血管紧张素转换酶抑制剂：剂量问题。
Br Heart J. 1994 Sep;72(3 Suppl):S106-10. doi: 10.1136/hrt.72.3_suppl.s106.
4
Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure.慢性心力衰竭中的血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂
Ann Intern Med. 2005 Mar 1;142(5):388; author reply 388-9. doi: 10.7326/0003-4819-142-5-200503010-00019.
5
Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂用于慢性心力衰竭
Ann Intern Med. 2005 Mar 1;142(5):388; author reply 388-9. doi: 10.7326/0003-4819-142-5-200503010-00018.
6
[Angiotensin converting enzyme inhibitors in arterial hypertension and cardiac failure. The question of the dose].[血管紧张素转换酶抑制剂在动脉高血压和心力衰竭中的应用。剂量问题]
Med Clin (Barc). 2000;114 Suppl 2:24-7.
7
Comparison of losartan and captopril in ELITE II.
Lancet. 2000 Sep 2;356(9232):852; author reply 852-3. doi: 10.1016/S0140-6736(05)73427-9.
8
ACE inhibitors in heart failure. What dose?心力衰竭中的血管紧张素转换酶抑制剂。用多大剂量？
Postgrad Med J. 1995 Feb;71(832):65-6. doi: 10.1136/pgmj.71.832.65.
9
Beta-blocker treatment before angiotensin-converting enzyme inhibitor therapy in newly diagnosed heart failure.
J Am Coll Cardiol. 2005 Jul 5;46(1):182. doi: 10.1016/j.jacc.2005.04.011.
10
Intermittent non-adherence with ACE inhibitor treatment and its implications for clinical trials results.ACE抑制剂治疗的间歇性不依从性及其对临床试验结果的影响。
Heart. 2001 Feb;85(2):213-4. doi: 10.1136/heart.85.2.213.
本文引用的文献
1
Double blind controlled study of low dose intravenous perindoprilat or enalaprilat infusion in elderly patients with heart failure.低剂量静脉注射培哚普利拉或依那普利拉治疗老年心力衰竭患者的双盲对照研究
Br Heart J. 1993 Apr;69(4):293-7. doi: 10.1136/hrt.69.4.293.
2
Comparison of captopril and enalapril in patients with severe chronic heart failure.卡托普利与依那普利治疗重度慢性心力衰竭患者的比较。
N Engl J Med. 1986 Oct 2;315(14):847-53. doi: 10.1056/NEJM198610023151402.
3
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.依那普利与肼屈嗪-硝酸异山梨酯治疗慢性充血性心力衰竭的比较。
N Engl J Med. 1991 Aug 1;325(5):303-10. doi: 10.1056/NEJM199108013250502.
4
Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II).早期应用依那普利对急性心肌梗死患者死亡率的影响。新斯堪的纳维亚依那普利协作生存研究II（CONSENSUS II）的结果。
N Engl J Med. 1992 Sep 3;327(10):678-84. doi: 10.1056/NEJM199209033271002.
5
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.卡托普利对心肌梗死后左心室功能不全患者死亡率和发病率的影响。生存与心室扩大试验的结果。SAVE研究人员。
N Engl J Med. 1992 Sep 3;327(10):669-77. doi: 10.1056/NEJM199209033271001.
Zotero 插件